Liver fibrosis: searching for cell model answers
- PMID: 17403182
- DOI: 10.1111/j.1478-3231.2007.01469.x
Liver fibrosis: searching for cell model answers
Abstract
Hepatic stellate cells (HSC) are the principal fibrogenic cell type in the liver. Progress in understanding the cellular and molecular basis for the development and progression of liver fibrosis could be possible by the development of methods to isolate HSC from rodents and human liver. Growth of stellate cells on plastic led to a phenotypic response known as activation, which paralleled closely the response of these cells to injury in vivo. Actually, much of the current knowledge of stellate cell behaviour has been gained through primary culture studies, particularly from rats. Also, different laboratories that have established hepatic stellate cell lines from rats and humans have provided a stable and unlimited source of cells that express specific functions, making them suitable for culture-based studies of hepatic fibrosis. From these in vitro models grew a large body of information characterizing stellate cell activation, cytokine signalling, intracellular pathways regulating liver fibrogenesis, production of extracellular matrix proteins and development of antifibrotic drugs.
Similar articles
-
Cirrhosis--can we reverse hepatic fibrosis?Eur J Surg Suppl. 2002;(587):100-12. Eur J Surg Suppl. 2002. PMID: 16144208 Review.
-
Hepatic stellate cells and the reversal of fibrosis.J Gastroenterol Hepatol. 2006 Oct;21 Suppl 3:S84-7. doi: 10.1111/j.1440-1746.2006.04584.x. J Gastroenterol Hepatol. 2006. PMID: 16958681 Review.
-
Mechanisms of disease: Mechanisms of hepatic fibrosis and therapeutic implications.Nat Clin Pract Gastroenterol Hepatol. 2004 Dec;1(2):98-105. doi: 10.1038/ncpgasthep0055. Nat Clin Pract Gastroenterol Hepatol. 2004. PMID: 16265071 Review.
-
Liver fibrosis: from the bench to clinical targets.Dig Liver Dis. 2004 Apr;36(4):231-42. doi: 10.1016/j.dld.2004.01.003. Dig Liver Dis. 2004. PMID: 15115333 Review.
-
Role of endogenous opioids in modulating HSC activity in vitro and liver fibrosis in vivo.Gut. 2008 Mar;57(3):352-64. doi: 10.1136/gut.2007.120303. Epub 2007 Nov 7. Gut. 2008. PMID: 17989109
Cited by
-
Highly Selective Artificial K+ Transporters Reverse Liver Fibrosis In Vivo.JACS Au. 2024 Aug 27;4(10):3869-3883. doi: 10.1021/jacsau.4c00521. eCollection 2024 Oct 28. JACS Au. 2024. PMID: 39483224 Free PMC article.
-
Roles of liver innate immune cells in nonalcoholic fatty liver disease.World J Gastroenterol. 2010 Oct 7;16(37):4652-60. doi: 10.3748/wjg.v16.i37.4652. World J Gastroenterol. 2010. PMID: 20872965 Free PMC article. Review.
-
Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver.Physiol Rev. 2008 Jan;88(1):125-72. doi: 10.1152/physrev.00013.2007. Physiol Rev. 2008. PMID: 18195085 Free PMC article. Review.
-
Phosphatidylinositol 3-kinase/Akt pathway regulates hepatic stellate cell apoptosis.World J Gastroenterol. 2008 Sep 7;14(33):5186-91. doi: 10.3748/wjg.14.5186. World J Gastroenterol. 2008. PMID: 18777595 Free PMC article.
-
Effect of hepato-toxins in the acceleration of hepatic fibrosis in hepatitis B mice.PLoS One. 2020 May 19;15(5):e0232619. doi: 10.1371/journal.pone.0232619. eCollection 2020. PLoS One. 2020. PMID: 32428024 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical